Abstract:Abstract Background: Accumulating clinical evidence demonstrated that gut microbiota (GM) transfer substantially ameliorated autistic symptoms, implying a role of GM in autism spectrum disorder (ASD). Continuous investigation reported GM alteration in ASD individuals, while inconsistency also persists in the abundance of bacterial taxon, as well as their metabolites. Due to deficiencies of stringent study designs, multi-omics assessment, and even animal tests, such data heterogeneity is yet to be addressed, which impedes establishing a causal effect of a specific microbiome-metabolome axis on pathogenesis of ASD.Results: We developed a participant recruitment and sampling procedure that fully considered possible intergroup and intragroup confounders, including age, diet, severity of ASD, and stool consistency. To tease out biological features of ASD from an overarching investigation on metabolome, composition and function of GM, we compared faecal samples collected from 123 children with either mild ASD (n=56) or typical development (TD) (n=67). Metabolite profiling of targeted metabolomics screened and validated a significantly higher ratio of gamma-aminobutyric acid (GABA) to glutamate (Glu) as a metabolic signature of ASD. Linked to autistic symptomatology, the microbial GABA/Glu ratio independently distinguished ASD from TD subjects, particularly at 3-5 years. The 16S rRNA gene sequencing displayed substantially declined GM richness but over-presented genus Escherichia in ASD, which was profoundly associated with the increased GABA/Glu ratio. Metagenomics confirmed both structural and metabolic dysbiosis of GM via revealing consistent changes in microbial components and Escherichia abundance, and highlighting overall hypofunction of the GM and imbalanced GABA/Glu synthesis in ASD. We further identified a series of E. coli-specific adhesins that linked Escherichia colonization with GABA production. Quantitative PCR validation supported increment of Escherichia-specific glutamate decarboxylase, promoting GABA synthesis. Further, challenge of healthy weaning mice with gut commensal E. coli induced significant social deficiency, but not abnormalities in repetitive, locomotor, recognition memory- and anxiety-related behaviors. Conclusions: Our multi-omics study elucidated a microbe-metabolite axis out of GM dysbiosis in mild ASD, characterized by over-presented Escherichia and concomitant GABA/Glu imbalance, which were well-marked features of ASD-linked GM at an early age, and potential causal factors of autistic symptomology. Our study provided insight into importance of microbial excitatory/inhibitory neurotransmitters imbalance in diagnosis and therapeutic treatment of ASD.

EphB6 regulates social behavior through gut microbiota-mediated vitamin B6 metabolism and excitation/inhibition balance of medial prefrontal cortex in mice

Gut microbiota regulates autism-like behavior by mediating vitamin B6 metabolism in EphB6-deficient mice

The gut microbiota regulates autism-like behavior by mediating vitamin B6 homeostasis in EphB6-deficient mice

Human-derived fecal microbiota transplantation alleviates social deficits of the BTBR mouse model of autism through a potential mechanism involving vitamin B6 metabolism

Changes to gut amino acid transporters and microbiome associated with increased E/I ratio in Chd8+/− mouse model of ASD-like behavior

Microbiota profiling reveals alteration of gut microbial neurotransmitters in a mouse model of autism-associated 16p11.2 microduplication

Excess Escherichia Elicits Mild Autism Spectrum Disorder in Young Subjects Via Disturbing the Balance of Gut Microbial GABA Metabolism

Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice

Microbiome-Specific Statistical Modeling Identifies Interplay Between Gastrointestinal Microbiome and Neurobehavioral Outcomes in Patients With Autism: A Case Control Study

Rescue of social deficits by early-life melatonin supplementation through modulation of gut microbiota in a murine model of autism

Gut microbiome and serum amino acid metabolome alterations in autism spectrum disorder

Supplier-origin gut microbiomes affect host body weight and select autism-related behaviors

Gut dysbiosis impairs hippocampal plasticity and behaviors by remodeling serum metabolome

Gut microbiota and autism spectrum disorders: a bidirectional Mendelian randomization study

Induction of autism-related behavior in male mice by early-life vitamin D deficiency: Association with disruption of gut microbial composition and homeostasis

Axin2 coupled excessive Wnt-glycolysis signaling mediates social defect in autism spectrum disorders

Interactions between the intestinal microbiota and epigenome in individuals with autism spectrum disorder

Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder

Congenitally underdeveloped intestine drives autism-related gut microbiota and behavior

Gut Microbial Profile Is Associated With the Severity of Social Impairment and IQ Performance in Children With Autism Spectrum Disorder

Alteration of Gut Microbiota: New Strategy for Treating Autism Spectrum Disorder